Lipid-lowering therapies and cardiovascular risk-stratification strategies in adults with...

NSR Lan, RSY Hong, C Ryan, AJ Jenkins… - Primary care diabetes, 2023 - Elsevier

Lipid-lowering reduces cardiovascular risk in type 1 diabetes (T1D), but dyslipidaemia
remains under-recognised and under-treated. Through patient surveys, barriers to lipid …

被引用次数：1 相关文章所有 5 个版本

Comparison of coronary artery calcium score and cardiovascular risk-stratification by European Society of Cardiology Guidelines and Steno Type 1 Risk Engine in …

YA Goh, NSR Lan, K Linn, C Wood, A Gupta… - Journal of Diabetes and …, 2023 - Elsevier

Background Coronary artery calcium (CAC) is a marker of atherosclerotic cardiovascular
disease (CVD). However, for patients with type 1 diabetes (T1D), its relationship with T1D …

Determinants of Vascular Impairment in Type 1 Diabetes; Impact of Sex and Connexin 37 Gene Polymorphism, Cross-sectional study.

P Pithova, M Cichrova, M Kvapil, J Hubacek, D Dlouha… - 2024 - researchsquare.com

Background Predictors of cardiovascular complications are well established in type 2
diabetes but not in type 1 diabetes (T1D). We analyzed the association between traditional …

[HTML] medicinetoday.com.au

[HTML][HTML] Type 1 diabetes–healthcare strategies for older people

D O'Neal - Medicine Today, 2024 - medicinetoday.com.au

Older people with type 1 diabetes represent a heterogeneous group, with varying ability to
self-manage their condition. A multidisciplinary approach to management, tailored to the …

[引用][C] Cardiovascular risk stratification in type 1 diabetes: do risk calculators and guidelines align?

K Hughes, NSR Lan, PG Fegan - Internal Medicine Journal, 2023 - europepmc.org

Cardiovascular risk stratification in type 1 diabetes: do risk calculators and guidelines align? -
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About …